Robinhood Markets, Inc. to Present at the Bernstein Strategic Decisions Conference on May 27, 2026
Get Alerts HOOD Hot Sheet
Join SI Premium – FREE
MENLO PARK, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will be participating in the upcoming Bernstein Strategic Decisions Conference on Wednesday, May 27, 2026.
Robinhood’s Chief Financial Officer Shiv Verma is scheduled to present on Wednesday, May 27, 2026, at 4:30 PM ET / 1:30 PM PT. Interested parties may access a live audio webcast of the presentation by visiting investors.robinhood.com. Following the presentation, a recording will be available for replay for at least 90 days on the same website.
About Robinhood
Robinhood Markets, Inc. (NASDAQ: HOOD) is a global leader in financial services offering retail brokerage, crypto, advisory, digital banking services, and private markets access to a new generation of investors. Additional information about Robinhood can be found at robinhood.com.
Robinhood uses the “Overview” tab of its Investor Relations website (accessible at investors.robinhood.com/overview) and its Newsroom (accessible at newsroom.aboutrobinhood.com), as means of disclosing information to the public in a broad, non-exclusionary manner for purposes of the SEC Regulation Fair Disclosure (Reg. FD). Investors should routinely monitor those web pages, in addition to Robinhood’s press releases, SEC filings, and public conference calls and webcasts, as information posted on them could be deemed to be material information.
“Robinhood” and the Robinhood feather logo are registered trademarks of Robinhood Markets, Inc. All other names are trademarks and/or registered trademarks of their respective owners.
Contacts
Investor Relations: [email protected]
Press: [email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robinhood plans $2B convertible notes offering due 2029
- Lion Group to acquire 10% stake in Indonesian stablecoin firm via shares
- AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Sanford C. BernsteinSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share